Sarepta Therapeutics (SRPT)
Create an Alert
39.76
+1.61 +4.22%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Sarepta Therapeutics Debt to Equity Ratio:
0.0199 for March 31, 2013Sarepta Therapeutics Historical Debt to Equity Ratio Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.0199 |
| Dec. 31, 2012 | 0.0142 |
| Sept. 30, 2012 | |
| June 30, 2012 | 0.08 |
| March 31, 2012 | 0.1299 |
| Dec. 31, 2011 | 0.0594 |
| Sept. 30, 2011 | 0.0586 |
| June 30, 2011 | 0.0536 |
| March 31, 2011 | 2.068 |
| Dec. 31, 2010 | |
| Sept. 30, 2010 | 0.4667 |
| June 30, 2010 | 0.2324 |
| March 31, 2010 | 0.0844 |
| Dec. 31, 2009 | 0.0847 |
| Sept. 30, 2009 | 0.1039 |
| June 30, 2009 | 0.538 |
| March 31, 2009 | 0.0898 |
| Dec. 31, 2008 | 0.1319 |
| Sept. 30, 2008 | 0.1278 |
| June 30, 2008 | 0.0992 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
SRPT Debt to Equity Ratio Benchmarks
| Companies | |
|---|---|
| Regeneron Pharmaceuticals | 0.2149 |
| Dendreon | |
| ACADIA Pharmaceuticals | 0.00 |
SRPT Debt to Equity Ratio Rankings
| Overall |
83rd percentile 2693 of 16782 |
| Sector |
75th percentile 350 of 1410 in Healthcare |
| Industry |
67th percentile 149 of 454 in Biotechnology |
SRPT Debt to Equity Ratio Range, Past 5 Years
| Minimum | 0.0142 | Dec 2012 |
| Maximum | 2.068 | Mar 2011 |
| Average | 0.2468 |
